High Levels of Endorphin and Related Pathologies of Veterinary Concern. A Review

References

• Kandel E. R., Schwartz J. H. Principles of Neural Science 2nd ed. Elsevier Science Publishing Co., New York 1985
   Google Scholar
• Rosenzwig M., Leiman A. Physiological Psychology. D.C. Heath and Co., Lexington 1982
   Google Scholar
• Chao D. M., Shen L. L., Tjen-A-Looi S., Pitsillides K. F., Li P., Longhurst J. C. Naloxone reverses inhibitory effects of electroacupuncture on sympathetic cardiovascular reflex responses. Am. J. Phisiol. 1999; 276: H2127
   Google Scholar
• Eckert R. Animal Physiology. W.H. Freeman and Co., New York 1988
   Google Scholar
• Shepherd G. M. Neurobiology 2^nd. Oxford Press, New York 1988
   Google Scholar
• Zadina J. E., Hackler L., Ge L. J., Kastin A. J. A potent and selective endogenous agonist for the mu-opiate receptor. Nature 1997; 386: 499
   PubMed Web of Science ®Google Scholar
• Hosohata K., Burkey T. H., Alfaro-Lopez J., Varga E., Hruby V. J., Roeske W. R., Yamamura H. I. Endomorphin-I and endomorphin-2 are partial agonist at the human mu-opioid receptor. Eur. J. Pharmacol. 1998; 346: 111
   PubMedGoogle Scholar
• Reisine T., Pasternak G. in The Pharmacological Basis Of Therapeutics, J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, A. Goodman, Gilman. McGrow-Hill. Inc., New York 1996; 521
   Google Scholar
• Restak R. The Mind. Bantam Books, New York 1988
   Google Scholar
• Prosser C. L. Neural and Integrative Animal Physiology. John Wiley and Sons, Inc., New York 1991
   Google Scholar
• Siegal G. Basic Chemistry 3^rd. Little Brown and Co., Boston 1981
   Google Scholar
• Joshi D., Bennett H. P., James S., Tousignant P., Miller M. M. Hypothalamic processing of β-endorphin in female C57BL/6J mice is altered at middle age. J. Endocrinol. 1995; 144: 405
   PubMedGoogle Scholar
• Goldberg I. E., Rossi G. C., Letchworth S. R., Mathis J. P., Ryan-Moro J., Levethal L., Su W., Emmel D., Boland E. A., Pasternak G. W. Pharmacological characterization of endomorphin-1 and endomorph-2 in mouse brain. J. Pharmacol. Exp. Ther. 1998; 286: 1007
   PubMed Web of Science ®Google Scholar
• Nishiwaki H., Saitoh N., Nishio H., Takeuchi T., Hata F. Inhibitory effect of endomorphin-1 and 2 on acetylcholine release from myenteric plexus of guinea pig ileum. Jpn. J. Pharmacol. 1998; 78: 83
   PubMedGoogle Scholar
• Kwok E. H., Dun N. J. Endomorphin decrease heart rate and blood pressure possibly by activating vagal afferents in anaesthetised rats. Brain Res. 1998; 803: 204
   PubMedGoogle Scholar
• Mima H., Morikawa H., Fukuda K., Kato S., Shoda T., Mori K. Ca2+ channel inhibition by endomorphins via the cloned mu-opioid receptor expressed in NG108–15 cells. Eur. J. Pharmacol. 1997; 340: R1
   PubMedGoogle Scholar
• Melchiorri P., Negri L. in Farmacologia generale e molecolare, R. Paoletti, S. Nicosia, F. Clementi, G. Fumagalli. UTET, Torino 1996; 277
   Google Scholar
• Katzung B. G. Farmacologia generale e clinica. Piccin, Padova 1992
   Google Scholar
• Genazzani E., Giotti A., Mantegazza P., Pepeu G., Periti P. Trattato di Farmacologia e Chemioterapia. USES, Firenze 1986; Vol. 2
   Google Scholar
• Shavit Y., Terman G. W., Martin F. C., Lewis J. W., Liebeskind J. C., Gale R. P. Stress, opioid peptides, the immune system, and cancer. J. Immunol. 1985; 135(2 suppl)834s
   Google Scholar
• Morgan E. L., McClurg M. R., Janda J. A. Suppression of Human B lymphocyte activation by betaendorphin. J. Neuroimmunol 1990; 28: 209
   PubMedGoogle Scholar
• Morch H., Pedersen B. K. Beta-endorphin and the immune system—possible role in autoimmune diseases. Autoimmunity 1995; 21: 161
   PubMed Web of Science ®Google Scholar
• Carpenter G. W., Breeden L., Can D. J. Acute exposure to morphine suppresses cytotoxic T-lymphocyte activity. Int. J. Immunopharmacol. 1995; 17: 1001
   PubMed Web of Science ®Google Scholar
• Lu Z. W., Dai W. J., Wang G. L., Lin Z. B. Subchronic in vivo treatments of morphine inhibit T-cell proliferation by acting on macrophages. Brain Behav. Immun. 1996; 10: 351
   PubMedGoogle Scholar
• Govitrapong P., Suttitum T., Kotchabhakdi N., Uneklabh T. Alterations of immune functions in heroin addicts and heroin withdrawal subjects. J. Pharmacol. Exp. Ther. 1998; 286: 883
   PubMed Web of Science ®Google Scholar
• Singhal Pravin C., Pan C., Gibbons N. Effect of Morphine on Uptake of immunoglobulin G complexes by mesangial cells macrophages. Am. J. Physiol. 1993; 264: F859
   Google Scholar
• Keren O., Gioannini T. L., Hiller J. M., Simon E. J. Affinity crosslinking of 1251-labeled human beta-endorphin to cell lines possessing either mu-or delta-type opioid binding sites. Brain Res. 1988; 440: 280
   PubMedGoogle Scholar
• Przewlocki R., Hassan A. H., Lason W., Epplen C., Hen A., Stein C. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience 1992; 48: 491
   PubMed Web of Science ®Google Scholar
• Machelska H., Cabot P. J., Mousa S. A., Zhang Q., Stein C. Pain Control in inflammation governed by selectins. Nat. Med. 1998; 4: 1425
   PubMedGoogle Scholar
• Minoia P., Sciorsci R. L. II ruolo del calcio nelle patologie endorfino mediate. Meccanismi Biologici. Possibilità diagnostiche. Orientamenti terapeutici. Accademia Pugliese delle Scienze, Grafischena, Fasano. 1994
   Google Scholar
• Stein C., Schafer M., Cabot P. J. Peripheral opioid analgesia. Pain Rev. 1997; 4: 171
   Google Scholar
• Mousa S. A., Schafer M., Mitchell W. M., Hassan A. H.S., Stein C. Local upregulation of corticotropin releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. Eur. J. Pharmacol. 1996; 311: 221
   PubMedGoogle Scholar
• Heijnen C. J., Kavelaars A., Ballieux R. E. β-Endorphin: Cytokine and neuropeptide. Immunol. Rev. 1991; 119: 41
   PubMed Web of Science ®Google Scholar
• Kowalski J. Immunomodulatory action of class mu-, delta-and kappa-opioid receptor agonisks in mice. Neuropeptides 1998; 32: 301
   PubMed Web of Science ®Google Scholar
• Molotkovskaya I. M., Malyukova I. V., Zakharova L. A. Opioid agonist modulation of cytoplasmic free Ca++ level in concanavalin A-stimulated mouse lymphocytes. Biochemistry 1999; 64: 546
   PubMedGoogle Scholar
• Buratti T., Scratzberger P., Dunzendorfer S., Manfreda S. E., Peachlaner C., Jannidis M., Sacerdote P., Panerai A. E., Wiedermann C. J. Decreased levels of beta-endorphin in circulating mononuclear leukmyte from patients with acute myocardial infarction. Cardiology 1998; 90: 43
   PubMed Web of Science ®Google Scholar
• Panerai A. E., Sacerdote P., Bianchi M., Manfredi B. Intermittent but not continuous inescapable footshock stress and intracerebroventricular interleukin-1 similarly affect immune responses and immunocyte beta-endorphin concentration in the rat. Int. J. Clin. Pharmacol. Res. 1997; 17: 115
   PubMedGoogle Scholar
• Pike J. L., Smith T. L., Hauger R. L., Nicassio P. M., Patterson T. L., McClintick J., Costlow C., Irwin M. R. Chronic life stress alters sympathetic, neuroendocrine and immune responsivity to an acute psychological stressor in humans. Psychosom. Med. 1997; 59: 447
   PubMed Web of Science ®Google Scholar
• Jonsdottir I. H., Hoffmann P., Thoren P. Physical exercise, endogenous opioids and immune function. Acta Physiol. Scand. Suppl. 1997; 640: 47
   PubMedGoogle Scholar
• De Riu P. L., Petmzi V., Caria M. A., Mameli O., Casu A. R, Nuvoli S., Spanu A., Madeddu G. Beta endorphin and cortisol levels in plasma and CSF following acute experimental spinal traumas. Physiol. Behav. 1997; 62: 1
   PubMedGoogle Scholar
• Cruse J. M., Keith J. C., Bryant M. L., Jr, Lewis R. E., Jr. Immune system-neuroendocrine dysregulation in spinal cord injury. Immunol. Res. 1996; 15: 306
   PubMedGoogle Scholar
• Aymerich M. S., Bengoechea-Alonso M. T., Lopez-Zabalza M. J., Santiago E., Lopez-Moratalla N. Inducible nitric oxide synphase (iNOS) expression in human monocytes triggered by beta-endorphin through an increase in cAMP. Biochem. Biophys. Res. Commun. 1998; 245: 717
   PubMedGoogle Scholar
• Levinthal C. Messengers of Paradise: Opiates and the Brain. Doubleaday, New York 1988
   Google Scholar
• Trafton J. A., Abbadie C., Marchand S., Mantyh P. W., Basbaum A. I. Spinal opioid analgesia: how critical is the regulation of substance P. Signaling. J. Neurosci. 1999; 19: 9642
   PubMedGoogle Scholar
• Page C. P., Curtis M. J., Sutter M. C., Walker M. j.a., Hoffman B. Integrated pharmacology. Mosby, London 1997
   Google Scholar
• Pu S., Horvath T. L., Diano S., Naftolin F., Kalra P. S., Kalra S. P. Evidence showing that beta-endorphin regulates cyclic guanosine 3′, 5′-monophosphate (cGMP) efflux: anatomical and functional support for an interaction between opiates and nitric oxide. Endocrinology 1997; 138: 1537
   PubMedGoogle Scholar
• Wilderman M. J., Armestead W. M. Role of neuronal NO synthase in relationship between NO andopioids in hypoxia-induced pial artery dilation. Am. J. Physiol. 1997; 273: H1–807
   Google Scholar
• Hauser K. F., Harris-White M. E., Jackson J. A., Opanashuk L. A., Carney J. M. Opioid disrupt Ca2+ homeostasis and induced carbonyl oxyradical production in mouse astrocytes in vitro: transient increase and adaptation to sustained exposure. Exp. Neurol. 1998; 151: 70
   PubMedGoogle Scholar
• Sciorsci R. L., Lacalandra G., Minoia P. Evoluzione terapeutica in clinica della riproduzione. Atti S.I.B. 1996; 28: 473
   Google Scholar
• Can J. A. β-endorphin inhibition of endogenous norepinephrine release from the A2 noradrenergic nucleus in vitro: role of mu opiate receptors and Na+ ion permeability. Brain Res. Bull 1997; 4: 19
   Google Scholar
• Evans C. J., Keith D. E., Morrison H., Magendzo K., Edwards R. H. Cloning of a Delta Opioid Receptor by Functional Expression. Science 1992; 258: 1952
   PubMed Web of Science ®Google Scholar
• Barker R. A. Neuroscience. Ellis Horwood, New York 1991
   Google Scholar
• Ehrenpreis S., Sicuteri F. Degradation of Endogenous Opioids: its Relevance in Human Pathology and Therapy. Raven Press, New York 1983
   Google Scholar
• Curtis M. T., Lefer A. M. Actions of opioate antagonists with selective receptor interactions in hemorrhagic shock. Circ. Shock 1983; 10: 131
   PubMedGoogle Scholar
• Panerai A. E., Martini A., Casanueva F., Petraglia F., Di Giulio A. M., Mantegazza P. Opiates and their antagonists modulate luteinizing hormone acting outside the blood brain barrier. Life Sci. 1983; 32: 1751
   PubMedGoogle Scholar
• Ingram S. L., Williams J. T. Opioid inhibition of Ih via adenylyl cyclase. Neuron 1994; 13: 179
   PubMed Web of Science ®Google Scholar
• Bianchi C. P. Cell Calcium Butterworth 1968; 1111: 65
   Google Scholar
• Bianchi C. P. Role of calcium channels in the sarcolemma and the sarcoplasmic reticulum in skeletal muscle functions. Adv. Exp. Med. Biol. 1992; 311: 237
   PubMedGoogle Scholar
• Sarada B., Thiele D., Dang T., Safavi A., Hersh L. B., Cottam G. L. Increased expression of an endopeptidase (gamma-EGE/IDE) hydrolyzing beta-endorphin during differentation and maturation of bone marrow macrophages. J. Leukoc. Biol. 1997; 62: 753
   PubMedGoogle Scholar
• Meng Q. C., Oparil S. Purification and assay methods for angiotensin-converting enzyme. J. Chromatogr. A 1996; 743: 105
   PubMed Web of Science ®Google Scholar
• Turner A. Neuropeptides and their peptidases. Ellis Horwood, New York 1987
   Google Scholar
• Puig M. M., Pol O. Peripheral effects of opiods in a model of chronic intestinal inflammation in mice. J. Pharmacol. Exp. Ther. 1998; 287: 1068
   PubMed Web of Science ®Google Scholar
• Hopson J., Wessells N. Essentials of Biology. McGraw-Hill Publishing Co., New York 1990
   Google Scholar
• Cesselin F., Benoliel J. J., Bourgoin S., Collin E., Phol M., Hamon M. in Opioids in pain control, C. Stein. University Press, Cambridge 1999; 70
   Google Scholar
• Suh H. W., Song D. K., Choi S. R., Huh S. O., Kim Y. H. Differential effects of omega-conotoxin GVIA, nimodipine calmidazolium and KN-62 injected intrathecally on the antinociception induced by beta-endorphin morphin, and [D-Ala2, N-MePhe4, Gly-o15]-enkephalin administered intracerebroventricularly in the mouse. J. Pharmacol. Exp. Ther. 1997; 282: 961
   PubMedGoogle Scholar
• Sacerdote P., Bianchi M., Panerai A. E. Involvement of beta-endorphin in the modulation of paw inflammatory edema in the rat. Regul. Pept. 1996; 63: 79
   PubMedGoogle Scholar
• Abdulla F. A, Smith P. A. Axotomy reduces the effect of analgesic opioids yet increases the effect of nociceptin on dorsal root ganglion neurons. J. Neurosci. 1998; 18: 9685
   PubMed Web of Science ®Google Scholar
• Kalra S. P., Sahu A., Kalra P. S. Ageing of the neuropeptidergic signals in rats. J. Reprod. Fert. Suppl. 1993; 46: 11
   PubMedGoogle Scholar
• Ghosh B. R., Wu J. C., Miller W. L. GnRH stimulated Ca++ mobilization is absent in anestrous ewe pituitaries. Biol. Reprod. 1994; 50((1 suppl))170, [Abstr. 462]
   Google Scholar
• De Marinis L., Mancini A., Valle D., Fiumara C., Conte G., Bianchi A., Perrelli M., Gentinella R., Giustina A. Physiological role of the opioid-cholinergic interaction in growth hormone neuroregulation: effect of sex and food intake. Metabolism 1997; 46: 740
   PubMedGoogle Scholar
• Amos M. L., Smith M. E. The effect of pyridostigmine administration on the expression of pro-opiomelanocortin-derived peptides in motoneurones. Neurotoxicology 1998; 19: 799
   PubMedGoogle Scholar
• Yokotani K., Osumi Y. Involvment of mu-receptor in endogenous opioid peptide-mediated inhibition of acetylcholine release from the rat stomach. Jpn. J. Pharmacol. 1998; 78: 93
   PubMedGoogle Scholar
• Pau K. Y., Spies H. G. Neuroendocrine signals in the regulation of gonadotropin-releasing hormone secretion. Chin. J. Phisiol. 1997; 40: 181
   PubMedGoogle Scholar
• Laxmi N. A., Vijayan E. Effects of chronic systemic administration of opioid peptides, naloxone and n-acetyl betaendorphin antiserum on gonadotropins and testicular functions in the rat. Indian J. Exp. Biol. 1998; 36: 361
   PubMedGoogle Scholar
• Yamauchi N., Shibasaki T., Wakabayashi I., Demura H. Brain beta-endorphin and other opioids are involved in restraint stress-induced stimulation of the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system, and the adrenal medulla in the rat. Brain Res. 1997; 777: 140
   Google Scholar
• Ornstein R., Swencionis C. The Healing Brain. The Guiford Press, NewYork 1991
   Google Scholar
• Troullos E., Haargreaverss K. M., Donne R. A. Ibuprofen elevates immunoreactive beta-endorphin levels in humans during surgical stress. Clin. Pharmacol. Ther. 1997; 62: 74
   PubMedGoogle Scholar
• Kjaer A. Neurohypphysial peptides. Histaminergic regulation and function in adenohypophysial secretion. Dan. Med. Bull 1996; 43: 391
   PubMedGoogle Scholar
• Jessop D. S., Douthwaite J. A., Conde G. L., Lightman S. L., Dayan C. M., Harbuz M. S. Effects of acute stress or centrally injected interleukin-lbeta on neuropeptide expression in the immune system. Stress 1997; 2: 133
   PubMedGoogle Scholar
• Legakis I., Saramantis A., Voros D., Chalevelakis G., Tolis G. Dissociation of ACTH, beta-endorphin and cortisol in graded sepsis. Horn. Metab. Res. 1998; 30: 570
   PubMedGoogle Scholar
• Berczi I., Chalmers I. M., Nagy E., Warrington R. J. The immune effects of neuropeptides. Baillieres Clin. Rheumatol. 1996; 10: 227
   PubMedGoogle Scholar
• Berridge M. J., Bootman D. M., Lipp P. P. Calcium-a life and death signal. Nature 1998; 395: 645
   PubMed Web of Science ®Google Scholar
• Means A R. Calcium, calmodulin and cell cycle regulation. FEBS Lett. 1994; 347: 1
   PubMedGoogle Scholar
• Sheng M., Thompson M. A., Greenberg M. E. CREB: a Ca2+ regulated transcription factor phosphorylated by calmodulin dependent kinases. Science 1991; 252: 1427
   PubMed Web of Science ®Google Scholar
• Bading H., Ginty D. D., Greenberg M. E. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 1993; 260: 181
   PubMed Web of Science ®Google Scholar
• Negulescu P. A., Shastri N., Cahalan M. D. Intracellular calcium dependence of gene expression in single T lymphocytes. Proc. Natl. Acad. Sci. 1994; 91: 2873
   PubMed Web of Science ®Google Scholar
• Bums K., Duggan B., Atkinson E. A., Famulski K. S., Nemer M., Bleackley R. C., Michalak M. Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature 1994; 367: 476
   PubMedGoogle Scholar
• Nicotera P., Zhivotovsky B., Orrenius S. Nuclear calcium transport and the role of calcium in apoptosis. Cell calcium 1994; 16: 279
   PubMed Web of Science ®Google Scholar
• Yin D., Mufson R. A., Wang R., Shi Y. Fas-mediated cell death promoted by opioids. Nature 1999; 397: 218
   PubMed Web of Science ®Google Scholar
• Shy Y. F., Sahai B. M., Green D. R. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and Thymocytes. Nature 1989; 339: 625
   PubMedGoogle Scholar
• Brunner T., Mogil R. J., LaFace D., Yoo N. J., Mahboubi A., Echeverri F., Martin S. J., Force W. R., Lynch D. H., Ware C. F., Green D. R. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995; 373: 441
   PubMed Web of Science ®Google Scholar
• Ghosh A., Greenberg M. E. Calcium signaling in neurons: molecular mechanism and cellular consequences. Science 1995; 268: 239
   PubMed Web of Science ®Google Scholar
• Clapham D. E. Calcium signaling. Cell 1995; 80: 259
   PubMed Web of Science ®Google Scholar
• Dolmetsch R. E., Levis R. S., Goodnow C. C., Healy J. I. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature 1997; 386: 855
   PubMed Web of Science ®Google Scholar
• Bauerle P. A., Henkel T. Function and activation of NF-kB in the immune system. Annu. Rev. Immunol. 1994; 12: 141
   PubMedGoogle Scholar
• Su B., Jacinto E., Hibi M., Kallunki T., Karin M., Ben-Neriah Y. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 1994; 77: 727
   PubMed Web of Science ®Google Scholar
• Karin M., Hunter T. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr. Biol. 1995; 5: 747
   PubMed Web of Science ®Google Scholar
• Rao A. NF-ATp: a transcription factor required for the coordinate induction of several cytokine genes. Immunol. Today 1994; 15: 274
   PubMedGoogle Scholar
• Healy J. I., Dolmetsch R. E., Timerman L. A., Cyster J. G., Thomas M. L., Crabtree G. R., Lewis R. S., Goodnow C. C. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 1997; 6: 419
   PubMed Web of Science ®Google Scholar
• Segal M., Manor D. Confocal microscopic imaging of [Ca2+], in cultured rat hippocampal neurons following exposure to N-methyl D-aspartate. J. Physiol. 1992; 448: 655
   PubMed Web of Science ®Google Scholar
• Dolmetsch R. E., Xu K., Lewis R. S. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 1998; 392: 933
   PubMed Web of Science ®Google Scholar
• O'Malley D. M. Calcium permeability of the neuronal nuclear envelope: evaluation using confocal voluines and intracellular perfusion. J. Neurosci 1994; 14: 5741
   PubMedGoogle Scholar
• Hardingham G. E., Chawla S., Johnson C. M., Bading H. Distint functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 1997; 385: 260
   PubMed Web of Science ®Google Scholar
• Jensen K. F., Ohmstede C. A., Fisher R. S., Sahyoun N. Nuclear and axonal localization of Ca2+/calmodulin-dependent protein kinase type Gr in rat cerebellar cortex. Roc. Natl. Acad. Sci. 1991; 88: 2850
   PubMed Web of Science ®Google Scholar
• Miranti C. K., Ginty D. D., Huang G., Chatila T., Greenberg M. E. Calcium activates serum response factor-dependent transcription by a Ras and Elk-1 independent mechanism that involves a Ca2+/calmodulin-dependent kinase. Mol. Cell. Biol. 1995; 15: 3672
   PubMedGoogle Scholar
• Albillos A., Carbone E., Gandia L., Garcia A. G., Pollo A. Opioid inhibition of Ca2+ channel subtypes in bovine chromaffin cells: selectivity of action and voltage-dependence. Eur. J. Neurosci. 1996; 8: 1561
   PubMedGoogle Scholar
• Brown E. M., Gamba G., Riccardi D., Lombard M., Butters R., Kifor O., Sun A., Hediger M. A., Lytton J., Hebert S. C. Cloning and characterization of an extracellular Ca (2+) sensing receptor from bovine parathyroid. Nature 1993; 366: 575
   PubMed Web of Science ®Google Scholar
• Tsukamoto K., Watanabe I., Shiba T., Emi M. Isolation and radiation hybrid mapping of a dinucleotide repeat polymorphism at the human calcium-sensing receptor (CASR) locus. J. Hum. Genet. 1998; 43: 280
   PubMedGoogle Scholar
• Nielsen P. K., Rasmussen A. K., Butters R., Feldt-Rassmussen U., Bendtzen K., Dim R., Brown E. M., Olgaard K. Inhibition of PTH secretion by interlukin-1 beta in bovine parathyroid glands in vitro is associated with an up-regulation of the calcium-sensing receptor mRNA. Biochem. Biophys. Res. Commun. 1997; 238: 880
   PubMed Web of Science ®Google Scholar
• Chattopadhyay N., Mithal A., Brown E. M. The calcium sensing receptor: a window into the physiology and pathophysiology of mineral ion metabolism. Endocr. Rev. 1996; 17: 289
   PubMed Web of Science ®Google Scholar
• Cheng I., Klingensmith M. E., Chattopadhyay N., Kifor O., Butters R. R., Soybell D. I., Brown E. M. Identification and localization of the extracellular calcium-sensing receptor in human breast. J. Clin. Endocrinol. Metab. 1998; 83: 703
   PubMedGoogle Scholar
• Hebert S. C., Brown E. M, Harris H. W. Role of the Ca (2+)-sensing receptor in divalent mineral ion homeostasis. J. Exp. Biol. 1997; 200: 295
   PubMed Web of Science ®Google Scholar
• Chattopadhyay N., Ye C. P., Yamaguchi T., Kifor O., Vassilev P. M., Nishimura R., Brown E. M. Extracellular calcium-sensing receptor in rat oligodendrocytes: expression and potential role in regulation of cellular proliferation and an outward K+ channel. Glia 1998; 24: 449
   PubMed Web of Science ®Google Scholar
• Brown E. M., Pollak M., Chou Y. H., Seidman C. E., Seidman J. G., Hebert S. C. Cloning and functional characterization of extracellular Ca (2+)-sensing receptors from parathyroid and kidney. Bone 1995; 17: 7S
   Google Scholar
• McNeil L., Hobson S., Nipper V., Rodland K. D. Functional calcium-sensing receptor in ovarian surface epithelial cells. Am. J. Obstet. Gynecol. 1998; 178: 305
   PubMedGoogle Scholar
• McGehee D. S., Aldersberg M., Liu K. P., Hsuing S., Heath M. J., Tamir H. Mechanism of extracellular Ca2+ receptor-stimulated hormone release from sheep thyroid parafollicular cells. J. Physiol. 1997; 502: 31
   PubMedGoogle Scholar
• Rutherford J. D. Pharmacologic management of angina and acute myocardial infarction. Am. J. Cardiol. 1993; 72: 16C
   Google Scholar
• Furberg C. D., Psaty B. M., Meyer J. V. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326
   PubMed Web of Science ®Google Scholar
• Sciorsci R L., Minoia P. Nuova ipotesi etiopatogenetica. del collasso puerperale nella Bovina, Proceedings 18^th World Buiatrics Congress 1994; 1: 337
   Google Scholar
• Moises H. C., Rusin K. I., Macdonald R. L. Mu and kappa-opioid receptors selectively reduce the same transient components of high-threshold calcium current in rat dorsal root ganglion sensory neurons. J. Neurosci. 1994; 14: 5903
   PubMedGoogle Scholar
• Osawa T., Nakao T., Moriyoshi M., Nakada K. Plasma beta-endorphin around parturition and its relationship to cortisol level and resumption of pituitary and ovarian functions in dairy cows. Anim. Reprod. Sci. 1998; 52: 27
   PubMedGoogle Scholar
• Hydbring E., Madej A., MacDonald E., Drugge-Boholm G., Berglund B., Olsson K. Hormonal changes during parturition in heifers and goats are related to the phases and severity of labour. J. Edocrinol. 1999; 160: 75
   Google Scholar
• Minoia P., Sciorsci R. L. Studio del collasso puerperale. Contributo Casistico. Ulteriore valutazione etiopatogenetica. Atti S.I.B. 1995; 27: 231
   Google Scholar
• Minoia P., Caira M., Dell'Aquila M. E., Sciorsci R. L. High level of endogenous opioid peptides (EOP) as a risk factor for milk fever, accepted at the 14th. International Congress on Animal Reproduction. Stockholm 2000
   Google Scholar
• Andre R. A. Sudden death following naloxone administration. Anesth. Analg. 1980; 59: 782
   PubMedGoogle Scholar
• Smith G., Pinnock C. Naloxone paradox or panacea. Br. J. Anesth. 1985; 57: 547
   PubMedGoogle Scholar
• Lograno M. D., Daniele E., Sciorsci R. L., Minoia P. The opioid antagonist Naloxone controls L-Type calcium channel activity, 1st World Congress on Calcium and. Vitamin D in Human Life 1996; 12, Abstr.
   Google Scholar
• Buzas B., Rosenberger J., Cox B. M. Ca2+/calmodulin dependent transcriptional activation of dclta-opioid receptor gene expression induced by membrane depolarization in NG108–15 cells. J. Neurochem. 1998; 70: 105
   PubMedGoogle Scholar
• Bell J. A. Selective blockade of spinal reflexes by omega-conotoxin in the isolated spinal cord of the neonatal rat. Neuroscience 1993; 52: 711
   PubMedGoogle Scholar
• Carabelli V., Lovallo M., Magnelli V., Zucker H., Carbone E. Voltage-dependent modulation of single N-Type Ca2+ channel Kinetics by receptor agonists in IMR32 cells. Biophys. J. 1996; 70: 2144
   PubMed Web of Science ®Google Scholar
• Adams D. J., Trequattrini C. Opioid receptor-mediated inhibition of omega-conotoxin GVIA-sensitive calcium channel currents in rat intracardiac neurons. J. Neurophysiol. 1998; 79: 753
   PubMedGoogle Scholar
• Vallar L., Vicentini L. in Farmacologia generale e molecolare, R. Paoletti, S. Nicosia, F. Clemeiiti, G. Fumagalli. UTET, Torino 1996; 60
   Google Scholar
• Graves C. R. in The Pharmacological Basis Of Therapeutics, J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Rubdon, A. Goodman, Gilman. McGraw-Hill, Inc., New York 1996; 939
   Google Scholar
• Wang D., Sadee W., Quillan J. M. Calmodulin binding to G protein-coupling domain of opioid receptors. J. Biol. Chem. 1999; 274: 22081
   PubMedGoogle Scholar
• Steinhoff M., Vergnolle N., Young S. H., Tognetto M., Amadesi S., Ennes H. S., Trevisani M., Hollenberg M. D., Wallace J. L., Caughey G. H., Mitchell S. E., Williams L. M., Geppetti P., Mayer E. A., Bunnett N. W. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat. Med. 2000; 6: 151
   PubMed Web of Science ®Google Scholar
• Patel V. K., Abbott L. C., Rattan A. K., Tejwani G. A. Increased methionine-enkephalin levels in genetically epileptic (tg/tg) mice. Brain Res. Bull 1991; 27: 849
   PubMedGoogle Scholar
• Smith M. E., Hughes S. Pro-opiomelanocortin neuropeptide receptors on developing and dystrophic muscle fibers. Mol. Chem. Neuropathol. 1993; 19: 137
   PubMedGoogle Scholar
• Weld J. M., Kamerling S. G., Combie J. D., Nugent T. E., Woods W. E., Oeltgen P., Tobin T. The effects of Naloxone on endotoxic and hemorrhagic shock in horses. Res. Commun. Chem. Pathol. Pharmacol. 1984; 44: 227
   PubMedGoogle Scholar
• Slominski A., Paus R., Wortsman J. On the potential role of proopiomelanocortin in skin physiology and pathology. Mol. Cell. Endocrinol. 1993; 93: C1
   PubMed Web of Science ®Google Scholar
• Chatikhine V. A., Delpech B., Duval C., Chauzy C., d'hiou J., Chevrier A. Expression of β-endorphin in human breast cancer and adenofibromas. Ann. N.Y. Acad. Sci. 1993; 680: 473
   PubMedGoogle Scholar
• Minoia P., Zanghi A., Sciorsci R. L., Gimbo A. Immunoistochemical demonstration of b-endorphin in mammary tumours in the bitch, Proceedings: 25^th World Veterinary Congress WVA. WSAVA, Yokohama 1995, Abstr. PS12.2
   Google Scholar
• Chemushenko E. F. Immunodeficency states in lung diseases and the possible ways for their correction. Lik Sprava 1992; 3: 6
   Google Scholar
• Sundar K. S., Kamaraju L. S., Dingfelder J., McMahon J., Gollapudi S., Wilson W. H., Kong L. Y., Hong J. S., Weiss J. M., Lee J. E. β-endorphin enhances the replication of neurotropic human immudeficiency virus in fetal perivascular microglia. J. Neuroimmunol. 1995; 6: 97
   Google Scholar
• Perez-Castrillon J. L, Perez-Arellano J. L., Garcia-Palomo J. D., Jimenez-Lopez A, De-Castro S. Opioids depress in vitro human monocyte chemotaxis. Immunopharmacology 1992; 23: 57
   PubMedGoogle Scholar
• Kawashinia S., Fukutake N., Nishian K., Asakuma S., Iwasaki T. Elevated plasma β-endorphin levels in patients with congestive heart failure. J. Am. Coll. Cardiol. 1991; 17: 53
   PubMedGoogle Scholar
• Koiwa M., Shiga H., Nakamura H., Yoshino S. Role of opioid peptide in rheumatoid arthritis–detection of β-endorphin in synovial tissue. Arerugi 1992; 41: 1423
   PubMedGoogle Scholar
• Guillemin R. Peptides in the brain: the new endocrinology of the neuron. Science 1978; 202: 390
   PubMed Web of Science ®Google Scholar
• Booth N. H., Mc Donald L. E. Farmacologia e terapeutica veterinaria. EMSI, Roma 1991
   Google Scholar
• Oka T. 5-HT and narcotic induced hypotermia. Gen. Pharmacol. 1978; 9: 151
   PubMedGoogle Scholar
• Shemano I., Wendel H. Effects of nieperidine hydrochloride and morphhe sulfate on the lung capacity of intact dogs. J. Phannacol. Exp. Ther. 1965; 149: 379
   PubMedGoogle Scholar
• Goldstein A. Heroin addiction: neurobiology, pharmacology, and policy. J. Psychoactive Drugs 1991; 23: 123
   PubMed Web of Science ®Google Scholar
• Flacke J. W., Flacke W. E., Williams G. D. Acute pulmonary, edema following naloxone reversal of high dose morphine anesthesia. Anesthesiology 1977; 47: 376
   PubMed Web of Science ®Google Scholar
• Paoletti R., Nicosia S., Clementi F., Fumagalli G. Neuropsicofarmacologia. UTET, Torino 1998
   Google Scholar
• Plumb D. C. Veterinary Drug Handbook. Iowa State University Press, Ames 1999
   Google Scholar
• Casavola V., Guerra L., Reshkin S. J., Camosino M., Di Sole F., Sciorsci R. L., Minoia P. The effect of Naloxone on intracellular calcium in epithelial cell system. Ist. World Congress on Calcium and Vitamin D in Human life 1996; 11, Abstr.
   Google Scholar
• Prie D., Friedllander G., Coureau C., Vandewalle A, Cassingena R., Ronco P. M. Role of adenosine on glugagon-induced cAMP in human cortical collecting duct cell line. Kidney Int. 1995; 47: 1310
   PubMed Web of Science ®Google Scholar
• Albrizio M., Dell'Aquila M. E., Sciorsci R. L., Maritato F., Minoia P. Effects of naloxone on bovine in vitro maturation and opioids μ-preceptor gene expression in the cumulus-oocyte complex. Theriogenology 2000; 53: 446
   Google Scholar
• Guerra L., Casavola V., Dell'Aquila M. E., Sciorsci R. L., Albrizio M., Minoia P. Naloxone and β-endorphins increase intracellular calcium in cumulus cells of bovine oocytes, accepted at Symposium Calcium as a Molecule for Cellular Integration, UK 2000
   Google Scholar
• Dell'Aquila M. E., Albrizio M., Zarrilli A., Sciorsci R. L., Manitato F., Minoia P. Effects of β-Endorphin on in vitro maturation of bovine oocytes, accepted at the 14^th International Congress on Animal Reproduction. Stockholm 2000
   Google Scholar
• Minoia P., Guena L., Reshkin S. J., Di Sole F., Bagorda A., Albrizio M., Sciorsci R. L., Casavola V. Naloxone increases calcium via mobilization of intracellular stores and the opening of calcium channels in a renal cell line derived from xenopus laevis, accepted at Symposium Calcium as a Molecule for Cellular Integration, UK 2000
   Google Scholar
• Zanghi A., Gimbo A., Nicotina P A, Sciorsci R. L. Localizzazione immunoistochimica di β-endorfina nel testicolo di cavallo. Atti S.I.S. Vet. 1997; 51: 515
   Google Scholar
• Zanghi A, Gimbo A., Nicotina P. A., Mmoia P., Sciorsci R. L., Ferm D. β-endorphin immunoistochemistry in equine female genital tract, Annual Meeting selcted abstracts. AMoI 1999; vol.1: 1631, Abstr.
   Google Scholar
• Mason R. P., Leeds P. R., Jacob R. F., Hough C. J., Zhang K. G., Mason P. E., Chuang D. M. Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells. J. Neurochem. 1999; 72: 1448
   PubMed Web of Science ®Google Scholar
• Sciorsci R. L., Albrizio M., Dell'Aquila M. E., Cinone M., Aiudi G., Lacalandra G. M., Ricci L., Minoia P. Follicular growth in anestrus mares treated with naloxone and calcium: role of opioids in the control of apoptosis in granulosa cells. Theriogenology 2000; 53: 382
   Google Scholar
• Lacalandra G. M., Sciorsci R. L., Ricci L., Minoia P. Effects of Naloxone and calcium administration on ovarian activity in anestrus mares. Theriogenology 2000; 53: 374
   Google Scholar
• Minoia P., Sciorsci R. L., Dell'Aquila M. E. Effects of naloxone on calcium turnover in cows affected by milk fever. submitted to Theriogenology 2000
   Google Scholar
• Sciorsci R. L., Robbe D., Di Matteo A., Lacalandra G. M., Minoia P. Treatment of ovarian follicular cysts in dairy cows with epidural calcium-naloxone and systemic GnRH administration: a preliminary field study, accepted at the 14^th International Congress on Animal Reproduction. Stockholm 2000
   Google Scholar
• Sciorsci R. L., Robbe D., Cavalli A., Buonavoglia D., Minoia P. Interazione tra oppioidi endogeni ed immunità. Influenza di calcio e Naloxone sui livelli anticorpali in pecore vaccinate nei confronti dell'lBR, Atti 13^th Congresso Nazionale S.I.P.A.O.C. 1998; 150
   Google Scholar
• Cinone M., Farstad W., Fougner J. A., Sanson G., Sciorsci R. L., Minoia P. Induction of Oesrus in the silver fox (Vulpes vulpes) by means of HCG, opioid antagonist and calcium, Proceedings: 23^th congress of the World small animal veterinary association 1998; 2: 740, Abstr.p. 314
   Google Scholar
• Robbe D., Lacalandra G., Zarrilli A., Campanella F., Sciorsci R. L. Livelli di idrossiprolina serica e monitoraggio clinico dell' involuzione uterina in bovine trattate con Naloxone e calcio. Atti S.I.B. 1999; 31: 231
   Google Scholar
• Minoia P. Deficit di calcio nell'intervallo parto concepimento nella bovina. Atti S.I.B 1999; 31: 228
   Google Scholar
• Cinone M., Aiudi G., Lacalandra G. M., Sciorsci R. L. Accrescimento follicolare nella cagna mediante modulazione neuroendocrina. Atti S.I.S. Vet. 1999; 53: 99
   Google Scholar
• Minoia P., Sciorsci R. L. Somministrazione epidurale di calcio gluconato e Naloxone. Attivia terapeutica in van processi fisiopatologici. Atti S.I.S. Vet. 1999; 53: 87
   Google Scholar
• Hirst G. A calcium window to the gut. Nature 1999; 399: 16
   PubMed Web of Science ®Google Scholar
• Daniel E. E., Fox-Threlkeld J. E.T. in Advances in the innervation of the gastrointestinal tract, G. H. Holle, J. D. Wood. Elsevier, Amsterdam 1992; 329
   Google Scholar
• Kummerle J. F., Grider J. R., Murthy K. S., Souquet J. C., Hellstrom P., Martin D. C., Makjlouf G. M. in Advances in the innervation of the gastrointestinal tract, G. H. Holle, J. D. Wood. Elsevier, Amsterdam 1992; 341
   Google Scholar
• Bagnol D., Mansour A., Akil H., Waston S. J. Localization of mu and kappa opioid receptors in ral colon by antibodies to the cloned opioid receptors. Analgesia 1995; 1: 4
   Google Scholar
• Bagnol D., Mansour A., Akil H., Waston S. J. Cellular localization and distribution of the cloned mu and kappa receptors in rat colon gastrointestinal tract. Neuroscience 1997; 81: 579
   PubMed Web of Science ®Google Scholar
• Sciorsci R. L., Zanilli A., Console A., Giannandrea B., Minoia P. Influence of Naloxone on calcium turnover in women, 3^rd International Symposium Women's Health and Menopause 1998; 68, Abstr.
   Google Scholar
• Sciorsci R. L., Zanilli A, Console A., Giannandrea B., Minoia P. Influence of Naloxone in postmenopausal women, accepted at Symposium Calcium as a Molecule for Cellular Integration, UK 2000
   Google Scholar
• Przewlocki R, Parsons K. L., Sweeney D. D., Trotter C., Netzeband J. G., Siggins G. R, Gruol D. L. Opioid enhancement of calcium oscillations and burst events involving NMDA receptors and L-type calcium channels in cultured hippocampal neurons. J. Neurosci. 1999; 19: 9705
   PubMedGoogle Scholar